æ±äº¬å€§åŠ(æ±å€§)ãšé 倩å 倧åŠã®äž¡è ã¯7æ7æ¥ã38â以äžã«äžæããäœæž©ãè žå 现èå¢ã®æŽ»æ§åãä»ããŠäºæ¬¡èæ±é žéãå¢å ãããããããŠã€ã«ã¹æ§èºçã®éçåãæå¶ããããšãååã¬ãã«ã§è§£æãããšå ±åã§çºè¡šããã
-

çºç±ããŠã€ã«ã¹æ§èºçã®éçåãæå¶ããã¡ã«ããºã (åºæ:é 倩å 倧Webãµã€ã)
åææã¯ãæ±å€§ å»ç§åŠç ç©¶æ ææçåœéç ç©¶ã»ã³ã¿ãŒ ãŠã€ã«ã¹åŠåéã®é·äºã¿ãªã¿å€§åŠé¢ç(ç ç©¶åœæ)ãæ±å€§ å»ç§åŠç ç©¶æã®äžæžçå¿åææãæ ¶å¿çŸ©å¡Ÿå€§åŠ(æ ¶å€§) å 端çåœç§åŠç ç©¶æã®çŠç°çå£ç¹ä»»ææãé 倩å 倧倧åŠé¢ å»åŠç ç©¶ç§ ç·å蚺çç§åŠã®å è€ä¿å€«ææãã®å ±åç ç©¶ããŒã ã«ãããã®ã詳现ã¯ãè±ãªã³ã©ã€ã³ç§åŠèªãNature Communicationsãã«æ²èŒãããã
ãããŸã§ãå£ç¯ã«ãã倿°æž©ã®å¯æå·®ãé«éœ¢åã«ããäœæž©ã®äœäžãªã©ããŠã€ã«ã¹ææåŸã®éç床ã«äžãã圱é¿ã«ã€ããŠè©³çްã«è§£æãããäŸããªãã£ãããšãããç ç©¶ããŒã ã¯ä»åã倿°æž©ãäœæž©ã«çç®ãã€ã³ãã«ãšã³ã¶ãŠã€ã«ã¹ãæ°åã³ãããŠã€ã«ã¹(SARS-CoV-2)ã«å¯Ÿããæµæåã«äžãã圱é¿ã«ã€ããŠè§£æãããšããã
ãŸãã倿°æž©ãäœæž©ãã€ã³ãã«ãšã³ã¶ææåŸã®éç床ã«äžãã圱é¿ãè§£æãããããããŠã¹ã4âã22âã36âã®æ¡ä»¶äžã§7æ¥é飌è²ã宿œããããšã22â飌è²ããŠã¹ãšæ¯èŒããŠ4â飌è²ããŠã¹ã¯åºç€äœæž©ãææã«äœäžããäžæ¹ã§ã36â飌è²ããŠã¹ã¯åºç€äœæž©ã38âãè¶ããããã«ãªãããšã確ããããããšããã
次ã«ããããã®ããŠã¹ã«ã€ã³ãã«ãšã³ã¶ãŠã€ã«ã¹ãçµéŒ»çã«ææãããåæž©åºŠæ¡ä»¶äžã§é£Œè²ããããšã22â飌è²ããŠã¹ãšæ¯ã¹4â飌è²ããŠã¹ã§ã¯ææåŸã«éçåãããã36â飌è²ããŠã¹ã§ã¯èŽæ»çãªææã«å¯ŸããŠæµæåãç²åŸããŠããããšãè§£æãããSARS-CoV-2ææã«å¯ŸããŠãåæ§ã«æµæåã®ç²åŸã確èªããããšããã
-

倿°æž©ãããŠã¹ã®åºç€äœæž©ãã€ã³ãã«ãšã³ã¶ææåŸã®éç床ã«äžãã圱é¿ã(a)ããŠã¹ãåæž©åºŠæ¡ä»¶äžã§é£Œè²ããéã®ãææåã®åºç€äœæž©(âå°ã¯åããŠã¹ã®å€)ã(bã»c)åæž©åºŠæ¡ä»¶ã§é£Œè²ãããããŠã¹ã«ã€ã³ãã«ãšã³ã¶(b)ãŸãã¯SARS-CoV-2(c)ãææãããææ14æ¥åŸãŸã§ã®çåçã芳å¯ããã(åºæ:é 倩å 倧Webãµã€ã)
以äžã®å®éšããç ç©¶ããŒã ã¯ã36â飌è²ããŠã¹ã®æµæåãåäžããçç±ãšããŠãçºç±ã«ããè žå 现èå¢ã掻æ§åããŠããããã§ã¯ãªãããšèå¯ãããã®æ€èšŒã®ãããããªãå®éšã宿œãå ·äœçã«ã¯ãããŠã¹ãéåžžã®ãšãµãšæ°Žéæ°Žãäžããã³ã³ãããŒã«ã°ã«ãŒããäœé£ç©ç¹ç¶é£ãšæ°Žéæ°Žãäžããäœé£ç©ç¹ç¶é£ã°ã«ãŒããéåžžã®ãšãµãšæçç©è³ªãæ··ããæ°Žéæ°Žãäžããæçç©è³ªã°ã«ãŒãã«åãã36âæ¡ä»¶äžã§é£Œè²ããåŸã€ã³ãã«ãšã³ã¶ãŠã€ã«ã¹ãçµéŒ»çã«ææããããšããã
ãããšãã©ã®ã°ã«ãŒããææååŸã®äœæž©ã¯38â以äžã«ä¿ãããŠãããã®ã®ãäœé£ç©ç¹ç¶é£ã°ã«ãŒããæçç©è³ªã°ã«ãŒãã¯æµæåã倱ãããŠããããšãåãã£ããšããããã®ããšãããæµæåã®ç²åŸã«ã¯çºç±ã«ããæž©ããããè žå 现èå¢ã®æŽ»æ§åãéèŠã§ããããšã瀺åããããšããã
-

äœæž©äžææã®ãŠã€ã«ã¹ææã«å¯Ÿããæµæåã«ã¯ãè žå 现èå¢ç±æ¥ä»£è¬ç©è³ªãéèŠã ã£ãã(aã»b)36â飌è²ããŠã¹ã«éåžžã®ãšãµãŸãã¯äœé£ç©ç¹ç¶éé£ãé£²ã¿æ°ŽãšããŠæ°Žéæ°ŽãŸãã¯æçç©è³ªæ°Žãäžãããããã€ã³ãã«ãšã³ã¶ãææãããææ14æ¥åŸãŸã§ã®ããŠã¹ã®äœæž©(a)ããã³çåç(b)ã芳å¯ããã(åºæ:é 倩å 倧Webãµã€ã)
ããã«ã36â飌è²ããŠã¹ã®äœå ã§èµ·ããŠããç¶æ³ãè§£æããããã4âã22âã36âã®å枩床æ¡ä»¶äžã§7æ¥é飌è²ãããããŠã¹ã®è¡æž ãµã³ãã«ãçšããŠã¡ã¿ãããŒã è§£æãè¡ããšãäžæ¬¡èæ±é žã§ãããã³ãŒã«é žããäºæ¬¡èæ±é žã§ãããããªãã·ã³ãŒã«é žã(DCA)ãããŠã«ãœããªãã·ã³ãŒã«é žã(UDCA)ã®æ¿åºŠã36â飌è²ããŠã¹ã®è¡äžã§ææã«é«ããªã£ãŠããããšãåãã£ããšããã
-

36â飌è²ããŠã¹ã«ãããè¡äžèæ±é žã¬ãã«ã®å¢å ã(a)DCAã®åæçµè·¯ããŸãèèã§ãã³ã¬ã¹ãããŒã«ãææã«ã³ãŒã«é žãªã©ã®äžæ¬¡èæ±é žãåæãããè žå 现èã®åãã«ããDCAãªã©ã®äºæ¬¡èæ±é žãžãšå€æãããã(bã»c)åæž©åºŠæ¡ä»¶äžã§7æ¥é飌è²ãããããŠã¹ã®è¡æž ã«å¯Ÿããã¡ã¿ãããŒã è§£æãè¡ãããã(b)ã³ãŒã«é žæ¿åºŠã(c)DCAæ¿åºŠã(d)UDCAæ¿åºŠãâå°ã¯ããããã®ããŠã¹ã®å€(åºæ:é 倩å 倧Webãµã€ã)
次ã«ã22â飌è²ããŠã¹ã«éåžžã®æ°Žéæ°ŽãŸãã¯DCAãUDCAãæ··ããæ°Žéæ°Žãäžããã€ã³ãã«ãšã³ã¶ãŠã€ã«ã¹ãçµéŒ»çã«ææããããšãDCAãUDCAãäžããããã°ã«ãŒãã§ã¯èºã®ãŠã€ã«ã¹éã奜äžçã®æ°ãæžå°ããææåŸã®çåçãææã«æ¹åããããšã確èªããããšããã
-

DCAã«ããã€ã³ãã«ãšã³ã¶éçåæå¶å¹æã22â飌è²ããŠã¹ã«éåžžã®æ°Žéæ°ŽããŸãã¯0.55mMã®DCA(aïœc)ãŸãã¯UDCA(d)ãæ··ããæ°Žéæ°Žãäžããããã€ã³ãã«ãšã³ã¶ãçµéŒ»çã«ææãããããã(a)ææ2æ¥ç®ãš3æ¥ç®ã®èºã®ãŠã€ã«ã¹ã®éã(b)ææ7æ¥ç®ã®èºã«æµžæœ€ãã奜äžçã®æ°ã(cã»d)ææ14æ¥ç®ãŸã§ã®ããŠã¹ã®çåç(åºæ:é 倩å 倧Webãµã€ã)
ãŸããèæ±é žå容äœãTGR5ãã®ã¢ãŽãã¹ãã®ãHY-14229ããã€ã³ãã«ãšã³ã¶ã®å¢æ®ãççåå¿ãæå¶ãã广ã調ã¹ããããå¹é€çްèããã¯ããã¡ãŒãžã«ã€ã³ãã«ãšã³ã¶ãŠã€ã«ã¹ãææããHY-14229ååšäžã§24æéã®å¹é€ãè¡ããšãHY-14229ååšäžã§ã¯ã€ã³ãã«ãšã³ã¶ã®å¢æ®ãææã«ããèªå°ãããIL-1βã®ç£çãæå¶ãããŠããããšãçªãæ¢ãããããšããã
-

èæ±é žå容äœã¢ãŽãã¹ãã«ããã€ã³ãã«ãšã³ã¶ã®å¢æ®æå¶å¹æã(a)MDCK现èã«ã€ã³ãã«ãšã³ã¶ãææãããHY-14229ååšäžã§24æéå¹é€ããããã®åŸã«å¹é€äžæž äžã®ãŠã€ã«ã¹éããã©ãŒã¯ã¢ãã»ã€æ³ã§æž¬å®ãããã(b)ããŠã¹éªšé«ãã¯ããã¡ãŒãžã«ã€ã³ãã«ãšã³ã¶ãææãããHY-14229ååšäžã§24æéå¹é€ãããåŸã«ãå¹é€äžæž äžã®IL-1βéãELSIAã§æž¬å®ãããã(c)HY-14229ã¯ãã€ã³ãã«ãšã³ã¶ã®å¢æ®ããã³ææã«ããèªå°ãããççåå¿ãæå¶ããŠãããšèãããããšãã(åºæ:é 倩å 倧Webãµã€ã)
æåŸã«ãCOVID-19æ£è ã®éç床ãšè¡æŒ¿äžã®èæ±é žã¬ãã«ã«çžé¢ãããã®ãã©ãããè§£æããæ£è ã軜çãäžççI/IIã®ã°ã«ãŒãã«åãããšãè¡æŒ¿äžã®éçåããŒã«ãŒã®ããã£ããªããŒã²ã³ããåŸè ã§ææã«é«ããªã£ãŠããããšã倿ãéã«ãèæ±é žã®äžçš®ã®ãã°ãªã·ã³æ±ååã³ãŒã«é žã(GCA)ã¯ãåŸè ã§ææã«äœããªã£ãŠããããšãããã£ããšããããã®ããšã¯ãããã«ãããŠãCOVID-19ã®éç床ãšèæ±é žã¬ãã«ã«éçžé¢é¢ä¿ãããããšã瀺ããŠãããšããã
ç ç©¶ããŒã ã¯ä»åã®ææã掻ãããä»åŸã¯é«éœ¢è ãã€ã³ãã«ãšã³ã¶ãSARS-CoV-2ã§éçåãããããªãã¡ã«ããºã ã®è§£æãã宿䞻ãšãŠã€ã«ã¹ã®å ±çã¡ã«ããºã ã®è§£æãèæ±é žå容äœãæšçãšãããŠã€ã«ã¹æ§èºçã®éçåãæããæ°ããæ²»çè¬ã®éçºã«åããç ç©¶ãæšé²ããäºå®ã§ãããšããŠããã